Dowling & Yahnke’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $552K | Buy |
+7,900
| New | +$552K | 0.03% | 270 |
|
|
2022
Q1 | – | Sell |
-1,900
| Closed | -$279K | – | 391 |
|
|
2021
Q4 | $279K | Buy |
+1,900
| New | +$279K | 0.01% | 329 |
|
|
2019
Q4 | – | Sell |
-4,300
| Closed | -$335K | – | 387 |
|
|
2019
Q3 | $335K | Sell |
4,300
-1,000
| -19% | -$77.9K | 0.03% | 256 |
|
|
2019
Q2 | $546K | Hold |
5,300
| – | – | 0.05% | 229 |
|
|
2019
Q1 | $388K | Buy |
+5,300
| New | +$388K | 0.04% | 217 |
|